Ventripoint Diagnostics Stock Buy Hold or Sell Recommendation
| VPT Stock | CAD 0.14 0.01 7.69% |
Assuming the 90 days horizon and your typical level of risk aversion, our recommendation regarding VentriPoint Diagnostics is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell VentriPoint Diagnostics given historical horizon and risk tolerance towards VentriPoint Diagnostics. When Macroaxis issues a 'buy' or 'sell' recommendation for VentriPoint Diagnostics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out VentriPoint Diagnostics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as VentriPoint and provide practical buy, sell, or hold advice based on investors' constraints. VentriPoint Diagnostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
VentriPoint |
Execute VentriPoint Diagnostics Buy or Sell Advice
The VentriPoint recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on VentriPoint Diagnostics. Macroaxis does not own or have any residual interests in VentriPoint Diagnostics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute VentriPoint Diagnostics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
VentriPoint Diagnostics Trading Alerts and Improvement Suggestions
| VentriPoint Diagnostics generated a negative expected return over the last 90 days | |
| VentriPoint Diagnostics has high historical volatility and very poor performance | |
| VentriPoint Diagnostics has some characteristics of a very speculative penny stock | |
| VentriPoint Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| VentriPoint Diagnostics has accumulated 274.38 K in total debt. VentriPoint Diagnostics has a current ratio of 0.55, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist VentriPoint Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, VentriPoint Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like VentriPoint Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for VentriPoint to invest in growth at high rates of return. When we think about VentriPoint Diagnostics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 49.18 K. Net Loss for the year was (4.87 M) with loss before overhead, payroll, taxes, and interest of (6.27 K). | |
| VentriPoint Diagnostics has accumulated about 713.21 K in cash with (3.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
VentriPoint Diagnostics Returns Distribution Density
The distribution of VentriPoint Diagnostics' historical returns is an attempt to chart the uncertainty of VentriPoint Diagnostics' future price movements. The chart of the probability distribution of VentriPoint Diagnostics daily returns describes the distribution of returns around its average expected value. We use VentriPoint Diagnostics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of VentriPoint Diagnostics returns is essential to provide solid investment advice for VentriPoint Diagnostics.
| Mean Return | -0.41 | Value At Risk | -7.14 | Potential Upside | 11.11 | Standard Deviation | 5.84 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of VentriPoint Diagnostics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
VentriPoint Diagnostics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (52.8K) | 512.3K | 8.7M | (4.1M) | (3.9M) | (3.7M) | |
| Free Cash Flow | (2.4M) | (1.1M) | (3.2M) | (4.1M) | (3.8M) | (4.0M) | |
| Other Non Cash Items | 276.6K | 204.4K | (26.5K) | 218.2K | 308.3K | 323.8K | |
| Net Income | (3.3M) | (1.9M) | (3.9M) | (4.9M) | (4.9M) | (4.6M) | |
| End Period Cash Flow | 13.8K | 526.0K | 9.3M | 5.2M | 1.3M | 1.5M | |
| Depreciation | 60.3K | 54.9K | 48.8K | 50.9K | 66.7K | 45.9K | |
| Change To Inventory | 38.2K | 30.8K | 32.2K | 176.7K | 203.2K | 213.3K | |
| Change To Netincome | 467.6K | (1.1M) | 403.2K | 572.4K | 658.3K | 691.2K | |
| Investments | (39.0K) | (27.4K) | (17.1K) | (3.8K) | (4.3K) | 0.0 |
VentriPoint Diagnostics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to VentriPoint Diagnostics or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that VentriPoint Diagnostics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a VentriPoint stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.44 | |
β | Beta against Dow Jones | 0.17 | |
σ | Overall volatility | 5.99 | |
Ir | Information ratio | -0.09 |
VentriPoint Diagnostics Volatility Alert
VentriPoint Diagnostics exhibits very low volatility with skewness of 0.96 and kurtosis of 3.43. VentriPoint Diagnostics is a potential penny stock. Although VentriPoint Diagnostics may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in VentriPoint Diagnostics. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on VentriPoint instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.VentriPoint Diagnostics Fundamentals Vs Peers
Comparing VentriPoint Diagnostics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze VentriPoint Diagnostics' direct or indirect competition across all of the common fundamentals between VentriPoint Diagnostics and the related equities. This way, we can detect undervalued stocks with similar characteristics as VentriPoint Diagnostics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of VentriPoint Diagnostics' fundamental indicators could also be used in its relative valuation, which is a method of valuing VentriPoint Diagnostics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare VentriPoint Diagnostics to competition |
| Fundamentals | VentriPoint Diagnostics | Peer Average |
| Return On Equity | -29.73 | -0.31 |
| Return On Asset | -1.37 | -0.14 |
| Operating Margin | (45.10) % | (5.51) % |
| Current Valuation | 21.4 M | 16.62 B |
| Shares Outstanding | 157.68 M | 571.82 M |
| Shares Owned By Insiders | 2.10 % | 10.09 % |
| Number Of Shares Shorted | 58.32 K | 4.71 M |
| Price To Earning | 47.50 X | 28.72 X |
| Price To Book | 7.13 X | 9.51 X |
| Price To Sales | 284.43 X | 11.42 X |
| Revenue | 49.18 K | 9.43 B |
| Gross Profit | (6.27 K) | 27.38 B |
| EBITDA | (4.86 M) | 3.9 B |
| Net Income | (4.87 M) | 570.98 M |
| Cash And Equivalents | 713.21 K | 2.7 B |
| Cash Per Share | 0.01 X | 5.01 X |
| Total Debt | 274.38 K | 5.32 B |
| Current Ratio | 0.56 X | 2.16 X |
| Book Value Per Share | (0.01) X | 1.93 K |
| Cash Flow From Operations | (3.8 M) | 971.22 M |
| Short Ratio | 0.01 X | 4.00 X |
| Earnings Per Share | (0.03) X | 3.12 X |
| Beta | 0.39 | -0.15 |
| Market Capitalization | 20.5 M | 19.03 B |
| Total Asset | 1.88 M | 29.47 B |
| Retained Earnings | (53.49 M) | 9.33 B |
| Working Capital | 240.09 K | 1.48 B |
| Net Asset | 1.88 M |
VentriPoint Diagnostics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as VentriPoint . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 105522.0 | |||
| Daily Balance Of Power | 0.5 | |||
| Rate Of Daily Change | 1.08 | |||
| Day Median Price | 0.13 | |||
| Day Typical Price | 0.13 | |||
| Price Action Indicator | 0.015 | |||
| Period Momentum Indicator | 0.01 |
About VentriPoint Diagnostics Buy or Sell Advice
When is the right time to buy or sell VentriPoint Diagnostics? Buying financial instruments such as VentriPoint Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2023 | 2024 (projected) | Working Capital | 771.0K | 751.2K | Market Cap | 46.3M | 48.6M |
Use Investing Ideas to Build Portfolios
In addition to having VentriPoint Diagnostics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Manufacturing Thematic Idea Now
Manufacturing
Companies that provide goods across residential, commercial and industrial construction such as machinery, tools, or lumber production. The Manufacturing theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Manufacturing Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for VentriPoint Stock Analysis
When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.